Free Content Association between Asymmetric Dimethylarginine and Neopterin in Patients with and without Angiographic Coronary Artery Disease

Authors: Murr, C.1; Meinitzer, A.2; Grammer, T.3; Schroecksnadel, K.1; Böhm, B. O.4; März, W.; Fuchs, D.1

Source: Scandinavian Journal of Immunology, Volume 70, Number 1, July 2009 , pp. 63-67(5)

Publisher: Wiley-Blackwell

Buy & download fulltext article:

You have access to the full text article on a website external to ingentaconnect.

Please click here to view this article on Wiley Online Library.

You may be required to register and activate access on Wiley Online Library before you can obtain the full text. If you have any queries please visit Wiley Online Library

Abstract:

The increase of circulating asymmetric dimethylarginine (ADMA) concentrations, a competitive inhibitor of the nitric oxide synthases, is associated with an increased cardiovascular risk and is considered to play a role in endothelial dysfunction. Recently, ADMA production was observed in stimulated human peripheral mononuclear cells. In this study, we examined a potential relationship between concentrations of ADMA and of the immune activation marker neopterin in patients scheduled for coronary angiography. In a cross-sectional approach, blood concentrations of ADMA, homocysteine, neopterin, folic acid and vitamins B6 and B12 were compared in 2030 patients, which were recruited as participants of the LUdwigshafen RIsk and Cardiovascular Health (LURIC) study. ADMA concentrations did not differ between patients with coronary artery disease (CAD) (mean ± SD: 0.82 ± 0.15 μmol/l) and controls (0.81 ± 0.14 μmol/l; Welch's t-test: P = n.s.). ADMA concentrations correlated with homocysteine (rs = 0.207) and vitamin B6 (rs = −0.190), and an even stronger correlation with neopterin (rs = 0.276; all P < 0.0001) was observed. In conclusion, increased ADMA concentrations in patients at risk for atherosclerosis are associated with increased neopterin concentrations. Data suggest that immune activation may contribute to increased ADMA production in CAD patients.

Document Type: Research article

DOI: http://dx.doi.org/10.1111/j.1365-3083.2009.02261.x

Affiliations: 1: Division of Biological Chemistry, Biocenter, Innsbruck Medical University, Innsbruck, Austria 2: Clinical Department of Medical and Chemical Laboratory Diagnostics, Graz Medical University, Graz, Austria 3: Synlab Center of Laboratory Diagnostics, Heidelberg, Germany 4: Division of Endocrinology, Department of Medicine, University Hospital, Ulm, Germany

Publication date: 2009-07-01

Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page